Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,737 | -9,761 | -4,532 | -15,022 | -10,891 |
| Depreciation Amortization | N/A | N/A | N/A | 1 | 1 |
| Other Working Capital | -622 | -513 | -756 | 392 | -39 |
| Other Operating Activity | 1,726 | 1,209 | 241 | 2,306 | 2,002 |
| Operating Cash Flow | $-11,633 | $-9,065 | $-5,047 | $-12,323 | $-8,927 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,715 | 5,715 | N/A | N/A | N/A |
| Common Stock Issued | 6,397 | 4,058 | 3,483 | 5,511 | 3,376 |
| Other Financing Activity | -440 | -336 | -331 | -763 | -430 |
| Financing Cash Flow | $11,672 | $9,436 | $3,151 | $4,748 | $2,946 |
| Beginning Cash Position | 5,787 | 5,787 | 5,787 | 13,362 | 13,362 |
| End Cash Position | 5,826 | 6,158 | 3,891 | 5,787 | 7,381 |
| Net Cash Flow | $39 | $371 | $-1,896 | $-7,575 | $-5,981 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,633 | -9,065 | -5,047 | -12,323 | -8,927 |
| Free Cash Flow | -11,633 | -9,065 | -5,047 | -12,323 | -8,927 |